Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients
Lung · 2025
DOI: 10.1007/s00408-025-00807-5 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Lung, 2025. Verfasst von Fangping Ding und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, No.8 Xi To…. Hauptthemen laut MEDLINE: Hepatopulmonary Syndrome, Liver Cirrhosis, Calcium-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Beijing Natural Science Foundation grant.
Abstract (Originalsprache)
BACKGROUND: Hepatopulmonary syndrome (HPS) is a severe complication in cirrhotic patients and characterized by abnormal intrapulmonary vasodilation (IPVD), resulting in impaired oxygenation. Recent studies highlight the pivotal role and clinical merit of Reticulocalbin 3 (RCN3) in interstitial pulmonary remodeling. OBJECTIVES: This study aimed to investigate the clinical value of plasma RCN3 for early diagnosis of HPS in cirrhotic patients. METHODS: This prospective observational study on a cohort including 41 healthy control subjects and 247 cirrhotic patients with/without HPS, in which most HPS occurs in the mild stage. Plasma levels of RCN3 and key HPS-associated vasoactive factors are compared between patients with and without HPS/IPVD. The predictive value of RCN3 for the diagnosis of HPS is further analyzed. RESULTS: Patients with HPS had a severe condition. Plasma RCN3 was decreased in cirrhotic patients versus health control, but it is significantly higher in patients with HPS/IPVD than without non-HPS/IPVD. Notably, RCN3 level is positively correlated with P(A-a)O2 and MELD scores as well as plasma levels of angiogenetic factors VEGF and AngII. Although the plasma levels of vasoactive factors were significantly different between HPS and non-HPS patients, only plasma RCN3 and albumin are independently associated with HPS in cirrhotic patients. Plasma RCN3 exhibits better predictive value in HPS diagnosis (RCN3, AUC = 0.657, 95% CI 0.571-0.744, p < 0.001). Interestingly, the combination of RCN3 and albumin achieves more efficiency in HPS prediction (AUC = 0.711, 95% CI 0.630-0.792, p < 0.0001). CONCLUSIONS: Circulating RCN3 is likely a relatively specific earlier biomarker for the prediction of early or latent HPS in cirrhotic patients, and the combination of RCN3-ALB can achieve more efficiency in HPS prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, No.8 Xi Tou Tiao, Youanmen Wai, Beijing, China.
- Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, N0.5 Jingyuan Road, Beijing, China.
- Department of Respiratory and Critical Care Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Hepatic Disease and Tumor Interventional Treatment Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Fourth Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Ultrasound and Functional Diagnosis Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Förderung
- Beijing Natural Science Foundation grant
Zitieren
APA
Ding, F., Yang, L., Cao, W., Sun, J., Shi, F., Wang, Y., Hu, C., Kang, W., Han, J., Song, Q., Ma, Y., & Jin, J. (2025). Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients. Lung. https://doi.org/10.1007/s00408-025-00807-5
Vancouver
Ding F, Yang L, Cao W, Sun J, Shi F, Wang Y, et al. Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients. Lung. 2025. doi:10.1007/s00408-025-00807-5
BibTeX
@article{Ding2025,
author = {Ding, Fangping and Yang, Liu and Cao, Wenhui and Sun, Jie and Shi, Fengwei and Wang, Yingfei and Hu, Caixia and Kang, Weiwei and Han, Jing and Song, Qingkun and Ma, Yingmin and Jin, Jiawei},
title = {Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients},
journal = {Lung},
year = {2025},
doi = {10.1007/s00408-025-00807-5}
}
EUVIMED